TABLE 1.
Baseline | Follow-up | P | |
---|---|---|---|
n | 831 | 831 | |
Age at blood collection,2 y | 45 ± 5 | 58 ± 4 | <0.001 |
BMI, kg/m2 | 24.6 ± 3.5 | 26.3 ± 4.7 | <0.001 |
Weight, kg | 66.4 ± 10.2 | 70.7 ± 12.8 | <0.001 |
Total energy intake, kcal/day | 1886 ± 364 | 1756 ± 409 | <0.001 |
Alcohol, g/day | 3.9 ± 5.8 | 6.2 ± 8.2 | <0.001 |
Current smokers, % | 4.1 | 1.5 | <0.001 |
Physical activity, MET-h/wk | 17.8 ± 15.2 | 23.5 ± 22.2 | <0.001 |
Postmenopausal, % | 20.6 | 72.1 | <0.001 |
Current PMH use in postmenopausal, % | 85.5 | 23.9 | <0.001 |
Hypertension, % | 10.9 | 29.4 | <0.001 |
Hypercholesterolemia, % | 15.1 | 35.1 | <0.001 |
PDI | 55.9 ± 4.8 | 57.8 ± 4.7 | <0.001 |
hPDI | 55.2 ± 5.7 | 54.3 ± 6.2 | 0.60 |
uPDI | 54.0 ± 5.7 | 48.0 ± 5.8 | <0.001 |
Plasma biomarkers | |||
Total adiponectin, µg/mL | 7.0 [1.4] | 7.4 [1.5] | <0.001 |
Leptin, ng/mL | 17.0 [1.8] | 19.4 [2.0] | <0.001 |
Soluble leptin receptor, ng/mL | 24.8 [1.2] | 25.0 [1.3] | <0.001 |
Free leptin index3 | 0.7 [2.0] | 0.8 [2.3] | 0.001 |
Insulin, µU/mL | 5.1 [1.6] | 5.5 [1.7] | 0.11 |
RBP-4, µg/mL | 32.8 [1.2] | 35.7 [1.2] | <0.001 |
High-sensitivity CRP, mg/L | 0.99 [2.55] | 1.03 [2.58] | 0.10 |
IL-6, pg/mL | 0.87 [1.54] | 0.91 [1.57] | 0.02 |
1Values are means ± SDs for continuous variables except plasma biomarkers, geometric means [geometric SDs] for all plasma biomarkers, and percentages for categorical variables; and are standardized to the age distribution of participants. P value is calculated based on paired t test (for continuous variables) or McNemar's test (for binary variables). CRP, C-reactive protein; hPDI, healthful plant-based diet index; MET-h, metabolic equivalent task hours; PDI, overall plant-based diet index; PMH, postmenopausal hormone; RBP-4, retinol-binding protein-4; uPDI, unhealthful plant-based diet index.
2Value is not age adjusted.
3Free leptin index is defined as the ratio of leptin to soluble leptin receptor.